Download PDF
Semin intervent Radiol 2006; 23(1): 047-063
DOI: 10.1055/s-2006-939841
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Epidemiology of Primary and Secondary Liver Cancers

Ashwin Ananthakrishnan1 , Veena Gogineni1 , Kia Saeian1
  • 1Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin
Further Information

Publication History

Publication Date:
04 April 2006 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Primary liver cancer is the sixth most common cancer worldwide with a wide geographic distribution. The incidence of primary liver cancer is increasing and there is still a higher prevalence in developing countries. Early recognition remains an obstacle and lack of it results in poor outcomes for hepatocellular carcinoma (HCC), the most prevalent primary liver cancer, and cholangiocarcinoma. The most common risk factors associated with HCC are hepatitis B and chronic hepatitis C infections, alcohol use, smoking, and aflatoxin exposure. Emerging risk factors such as obesity might play an important role in the future because of the increasing prevalence of this condition.

KEYWORDS

Primary liver cancer - hepatocellular carcinoma - cholangiocarcinoma - chronic hepatitis B - chronic hepatitis C

REFERENCES

  • 1 El-Serag H B. Hepatocellular carcinoma: an epidemiologic view.  J Clin Gastroenterol. 2002;  35 S72-S78
    CrossrefPubMedSearch in Google Scholar
  • 2 Lenhard R, Osteen RT, Gansler T Clinical Oncology. Atlanta, GA; Blackwell Publishing, Inc 2001
    Search in Google Scholar
  • 3 Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002.  CA Cancer J Clin. 2005;  55 74-108
    Search in Google Scholar
  • 4 McGlynn K A, Tsao L, Hsing A W, Devesa S S, Fraumeni Jr J F. International trends and patterns of primary liver cancer.  Int J Cancer. 2001;  94 290-296
    CrossrefPubMedSearch in Google Scholar
  • 5 Kew M C. Hepatic tumors and cysts. In: Feldman M, Friedman LS, Sleisenger MH, Scharschmidt BF Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 7th ed. Philadelphia; Saunders 2002: 1583-1588
    Search in Google Scholar
  • 6 Fong Y, Kemeny N, Lawrence T S. Cancer of the liver and biliary tree. In: Devita VT, Hellman S, Rosenberg SA Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia; Lippincott Williams and Wilkins 2001: 1162-1187
    Search in Google Scholar
  • 7 Kiyosawa K, Umemura T, Ichijo T et al.. Hepatocellular carcinoma: recent trends in Japan.  Gastroenterology. 2004;  127 S17-S26
    CrossrefPubMedSearch in Google Scholar
  • 8 Bosch F X, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends.  Gastroenterology. 2004;  127 S5-S16
    CrossrefPubMedSearch in Google Scholar
  • 9 Ries LAG, Eisner MP, Kosary CL, et al SEER Cancer Statistics Review, 1975-2002. Bethesda, MD; National Cancer Institute 2005 Available at: http://seer.cancer.gov/csr/1975_2002
    Search in Google Scholar
  • 10 Surveillance, Epidemiology, and End Results (SEER) Program .http://Available at: www.seer.cancer.gov SEER*Stat Databases. Incidence-SEER 13 Regs Public-Use, Nov 2004 Sub for Expanded Races (1992-2002) and Incidence-SEER 13 Regs excluding AK Public-Use, Nov 2004 Sub for Hispanics (1992-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch released April 2005, based on the November 2004 submission. 
  • 11 Di Bisceglie A M, Order S E, Klein J L et al.. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.  Am J Gastroenterol. 1991;  86 335-338
    PubMedSearch in Google Scholar
  • 12 Hassan M M, Frome A, Patt Y Z, El-Serag H B. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.  J Clin Gastroenterol. 2002;  35 266-269
    CrossrefPubMedSearch in Google Scholar
  • 13 Godley P A, Sandler R S. Liver cancer. In: Everhart JE Digestive Diseases in United States: Epidemiology and Impact. Washington, DC; Government Printing Office 1994: 227-241
    Search in Google Scholar
  • 14 Kew M C. Hepatic tumors and cysts. In: Feldman M, Friedman LS, Sleisenger MH, Scharschmidt BF Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 7th ed. Philadelphia; Saunders 2002: 1577-1602
    Search in Google Scholar
  • 15 Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.  Hepatology. 1995;  21 650-655
    CrossrefPubMedSearch in Google Scholar
  • 16 Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and development of hepatocellular carcinoma.  Liver. 1995;  15 159-163
    PubMedSearch in Google Scholar
  • 17 Sherlock S. Viruses and hepatocellular carcinoma.  Gut. 1994;  35 828-832
    PubMedSearch in Google Scholar
  • 18 Yarrish R L, Werner B G, Blumberg B S. Association of hepatitis B virus infection with hepatocellular carcinoma in American patients.  Int J Cancer. 1980;  26 711-715
    PubMedSearch in Google Scholar
  • 19 Alter M J. Epidemiology of hepatitis C.  Hepatology. 1997;  26 62S-65S
    CrossrefPubMedSearch in Google Scholar
  • 20 Kelen G D, Green G B, Purcell R H et al.. Hepatitis B and hepatitis C in emergency department patients.  N Engl J Med. 1992;  326 1399-1404
    CrossrefPubMedSearch in Google Scholar
  • 21 McQuillan G M, Alter M J, Everhart J E. Viral hepatitis. In: Everhart JE Digestive Diseases in the United States: Epidemiology and Impact. Washington, DC; Government Printing Office 1994: 127-156
    Search in Google Scholar
  • 22 Centers for Disease Control and Prevention (CDC) . Incidence of acute hepatitis B: United States, 1990-2002.  MMWR Morb Mortal Wkly Rep. 2004;  52 1252-1254
    PubMedSearch in Google Scholar
  • 23 Feitelson M A. Hepatitis B virus in hepatocarcinogenesis.  J Cell Physiol. 1999;  181 188-202
    CrossrefPubMedSearch in Google Scholar
  • 24 Shimada M, Rikimaru T, Sugimachi K et al.. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver.  J Am Coll Surg. 2000;  191 531-537
    CrossrefPubMedSearch in Google Scholar
  • 25 Di Bisceglie A M, Rustgi V K, Hoofnagle J H, Dusheiko G M, Lotze M T. NIH conference: hepatocellular carcinoma.  Ann Intern Med. 1988;  108 390-401
    PubMedSearch in Google Scholar
  • 26 Chang M H, Shau W Y, Chen C J et al.. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls.  JAMA. 2000;  284 3040-3042
    CrossrefPubMedSearch in Google Scholar
  • 27 Armstrong G L, Alter M J, McQuillan G M, Margolis H S. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.  Hepatology. 2000;  31 777-782
    CrossrefPubMedSearch in Google Scholar
  • 28 Davis G L, Balart L A, Schiff E R et al.. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group.  N Engl J Med. 1989;  321 1501-1506
    PubMedSearch in Google Scholar
  • 29 Di Bisceglie A M, Martin P, Kassianides C et al.. Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial.  N Engl J Med. 1989;  321 1506-1510
    PubMedSearch in Google Scholar
  • 30 Manns M P, McHutchison J G, Gordon S C et al.. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.  Lancet. 2001;  358 958-965
    CrossrefPubMedSearch in Google Scholar
  • 31 McHutchison J G, Gordon S C, Schiff E R et al.. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.  N Engl J Med. 1998;  339 1485-1492
    CrossrefPubMedSearch in Google Scholar
  • 32 Ikeda K, Kobayashi M, Saitoh S et al.. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot study.  J Gastroenterol Hepatol. 2005;  20 95-102
    CrossrefPubMedSearch in Google Scholar
  • 33 Ikeda K, Saitoh S, Suzuki Y et al.. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study.  Cancer. 1998;  82 827-835
    CrossrefPubMedSearch in Google Scholar
  • 34 Mazzella G, Accogli E, Sottili S et al.. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.  J Hepatol. 1996;  24 141-147
    CrossrefPubMedSearch in Google Scholar
  • 35 Oon C J. Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions.  Cancer Chemother Pharmacol. 1992;  31(suppl) S137-S142
    CrossrefPubMedSearch in Google Scholar
  • 36 Wong J B, Koff R S, Tine F, Pauker S G. Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.  Ann Intern Med. 1995;  122 664-675
    PubMedSearch in Google Scholar
  • 37 Dienstag J L, Perrillo R P, Schiff E R, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection.  N Engl J Med. 1995;  333 1657-1661
    CrossrefPubMedSearch in Google Scholar
  • 38 Dienstag J L, Schiff E R, Wright T L et al.. Lamivudine as initial treatment for chronic hepatitis B in the United States.  N Engl J Med. 1999;  341 1256-1263
    CrossrefPubMedSearch in Google Scholar
  • 39 Lai C L, Chien R N, Leung N W et al.. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.  N Engl J Med. 1998;  339 61-68
    CrossrefPubMedSearch in Google Scholar
  • 40 Walsh K M, Woodall T, Lamy P, Wight D G, Bloor S, Alexander G J. Successful treatment with adefovir dipivoxil in a patient with fibrosing cholestatic hepatitis and lamivudine resistant hepatitis B virus.  Gut. 2001;  49 436-440
    CrossrefPubMedSearch in Google Scholar
  • 41 de Man R A, Wolters L M, Nevens F et al.. Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.  Hepatology. 2001;  34 578-582
    CrossrefPubMedSearch in Google Scholar
  • 42 Hassan M M, Hwang L Y, Hatten C J et al.. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.  Hepatology. 2002;  36 1206-1213
    CrossrefPubMedSearch in Google Scholar
  • 43 Jee S H, Ohrr H, Sull J W, Samet J M. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.  J Natl Cancer Inst. 2004;  96 1851-1856
    CrossrefPubMedSearch in Google Scholar
  • 44 La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S. Risk factors for hepatocellular carcinoma in northern Italy.  Int J Cancer. 1988;  42 872-876
    PubMedSearch in Google Scholar
  • 45 Marrero J A, Fontana R J, Fu S, Conjeevaram H S, Su G L, Lok A S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.  J Hepatol. 2005;  42 218-224
    PubMedSearch in Google Scholar
  • 46 Mayans M V, Calvet X, Bruix J et al.. Risk factors for hepatocellular carcinoma in Catalonia, Spain.  Int J Cancer. 1990;  46 378-381
    PubMedSearch in Google Scholar
  • 47 Sun C A, Wu D M, Lin C C et al.. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan.  Am J Epidemiol. 2003;  157 674-682
    CrossrefPubMedSearch in Google Scholar
  • 48 Yu M C, Tong M J, Govindarajan S, Henderson B E. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California.  J Natl Cancer Inst. 1991;  83 1820-1826
    PubMedSearch in Google Scholar
  • 49 Yuan J M, Govindarajan S, Arakawa K, Yu M C. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US.  Cancer. 2004;  101 1009-1017
    CrossrefPubMedSearch in Google Scholar
  • 50 Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in northern Italy.  Eur J Cancer. 1997;  33 629-634
    CrossrefPubMedSearch in Google Scholar
  • 51 Donato F, Tagger A, Chiesa R et al.. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.  Hepatology. 1997;  26 579-584
    CrossrefPubMedSearch in Google Scholar
  • 52 Tsutsumi M, Ishizaki M, Takada A. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis.  Alcohol Clin Exp Res. 1996;  20 758-762
    PubMedSearch in Google Scholar
  • 53 Tsukuma H, Hiyama T, Oshima A et al.. A case-control study of hepatocellular carcinoma in Osaka, Japan.  Int J Cancer. 1990;  45 231-236
    PubMedSearch in Google Scholar
  • 54 Donato F, Tagger A, Gelatti U et al.. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.  Am J Epidemiol. 2002;  155 323-331
    CrossrefPubMedSearch in Google Scholar
  • 55 Tanaka K, Hirohata T, Takeshita S et al.. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan.  Int J Cancer. 1992;  51 509-514
    PubMedSearch in Google Scholar
  • 56 Evans A A, Chen G, Ross E A, Shen F M, Lin W Y, London W T. Eight-year follow-up of the 90,000-person Haimen City cohort. I: hepatocellular carcinoma mortality, risk factors, and gender differences.  Cancer Epidemiol Biomarkers Prev. 2002;  11 369-376
    PubMedSearch in Google Scholar
  • 57 Zhang J Y, Wang X, Han S G, Zhuang H. A case-control study of risk factors for hepatocellular carcinoma in Henan, China.  Am J Trop Med Hyg. 1998;  59 947-951
    PubMedSearch in Google Scholar
  • 58 Goritsas C P, Athanasiadou A, Arvaniti A, Lampropoulou-Karatza C. The leading role of hepatitis B and C viruses as risk factors for the development of hepatocellular carcinoma: a case control study.  J Clin Gastroenterol. 1995;  20 220-224
    PubMedSearch in Google Scholar
  • 59 Naccarato R, Farinati F. Hepatocellular carcinoma, alcohol, and cirrhosis: facts and hypotheses.  Dig Dis Sci. 1991;  36 1137-1142
    CrossrefPubMedSearch in Google Scholar
  • 60 Bralet M P, Regimbeau J M, Pineau P et al.. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases.  Hepatology. 2000;  32 200-204
    CrossrefPubMedSearch in Google Scholar
  • 61 Chiesa R, Donato F, Tagger A et al.. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.  Cancer Epidemiol Biomarkers Prev. 2000;  9 213-216
    PubMedSearch in Google Scholar
  • 62 Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet J C. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire.  J Hepatol. 1999;  31 508-513
    CrossrefPubMedSearch in Google Scholar
  • 63 Cordier S, Le T B, Verger P et al.. Viral infections and chemical exposures as risk factors for hepatocellular carcinoma in Vietnam.  Int J Cancer. 1993;  55 196-201
    PubMedSearch in Google Scholar
  • 64 Yu M W, Hsu F C, Sheen I S et al.. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.  Am J Epidemiol. 1997;  145 1039-1047
    PubMedSearch in Google Scholar
  • 65 Kuper H, Tzonou A, Kaklamani E et al.. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma.  Int J Cancer. 2000;  85 498-502
    CrossrefPubMedSearch in Google Scholar
  • 66 Mastrangelo G, Fedeli U, Fadda E et al.. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake.  Environ Health Perspect. 2004;  112 1188-1192
    PubMedSearch in Google Scholar
  • 67 Bradbear R A, Bain C, Siskind V et al.. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.  J Natl Cancer Inst. 1985;  75 81-84
    PubMedSearch in Google Scholar
  • 68 Hsing A W, McLaughlin J K, Olsen J H, Mellemkjar L, Wacholder S, Fraumeni Jr J F. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark.  Int J Cancer. 1995;  60 160-162
    PubMedSearch in Google Scholar
  • 69 Davila J A, Morgan R O, Shaib Y, McGlynn K A, El-Serag H B. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.  Gut. 2005;  54 533-539
    CrossrefPubMedSearch in Google Scholar
  • 70 El-Serag H B, Richardson P A, Everhart J E. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.  Am J Gastroenterol. 2001;  96 2462-2467
    CrossrefPubMedSearch in Google Scholar
  • 71 Cauza E, Peck-Radosavljevic M, Ulrich-Pur H et al.. Mutations of the HFE gene in patients with hepatocellular carcinoma.  Am J Gastroenterol. 2003;  98 442-447
    CrossrefPubMedSearch in Google Scholar
  • 72 Elmberg M, Hultcrantz R, Ekbom A et al.. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.  Gastroenterology. 2003;  125 1733-1741
    CrossrefPubMedSearch in Google Scholar
  • 73 Gelatti U, Donato F, Tagger A et al.. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival.  Am J Gastroenterol. 2003;  98 907-914
    CrossrefPubMedSearch in Google Scholar
  • 74 Fracanzani A L, Conte D, Fraquelli M et al.. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.  Hepatology. 2001;  33 647-651
    CrossrefPubMedSearch in Google Scholar
  • 75 Blumberg R S, Chopra S, Ibrahim R et al.. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.  Gastroenterology. 1988;  95 1399-1402
    PubMedSearch in Google Scholar
  • 76 Deugnier Y M, Guyader D, Crantock L et al.. Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.  Gastroenterology. 1993;  104 228-234
    PubMedSearch in Google Scholar
  • 77 Goh J, Callagy G, McEntee G, O'Keane J C, Bomford A, Crowe J. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.  Eur J Gastroenterol Hepatol. 1999;  11 915-919
    PubMedSearch in Google Scholar
  • 78 Thompson N P, Stansby G, Jarmulowicz M, Hobbs K E, McIntyre N. Hepatocellular carcinoma arising in non-cirrhotic haemochromatosis.  HPB Surg. 1995;  8 163-166
    PubMedSearch in Google Scholar
  • 79 Fellows I W, Stewart M, Jeffcoate W J, Smith P G, Toghill P J. Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis.  Gut. 1988;  29 1603-1606
    PubMedSearch in Google Scholar
  • 80 Boige V, Castera L, de Roux N et al.. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.  Gut. 2003;  52 1178-1181
    CrossrefPubMedSearch in Google Scholar
  • 81 Racchi O, Mangerini R, Rapezzi D et al.. Mutations of the HFE gene and the risk of hepatocellular carcinoma.  Blood Cells Mol Dis. 1999;  25 350-353
    CrossrefPubMedSearch in Google Scholar
  • 82 Fargion S, Stazi M A, Fracanzani A L et al.. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.  Blood Cells Mol Dis. 2001;  27 505-511
    CrossrefPubMedSearch in Google Scholar
  • 83 Hellerbrand C, Poppl A, Hartmann A, Scholmerich J, Lock G. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.  Clin Gastroenterol Hepatol. 2003;  1 279-284
    CrossrefPubMedSearch in Google Scholar
  • 84 Lauret E, Rodriguez M, Gonzalez S et al.. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.  Am J Gastroenterol. 2002;  97 1016-1021
    CrossrefPubMedSearch in Google Scholar
  • 85 Pirisi M, Toniutto P, Uzzau A et al.. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients.  Cancer. 2000;  89 297-302
    CrossrefPubMedSearch in Google Scholar
  • 86 Fargion S, Piperno A, Fracanzani A L, Cappellini M D, Romano R, Fiorelli G. Iron in the pathogenesis of hepatocellular carcinoma.  Ital J Gastroenterol. 1991;  23 584-588
    PubMedSearch in Google Scholar
  • 87 Mallory M A, Kowdley K V. Hereditary hemochromatosis and cancer risk: more fuel to the fire?.  Gastroenterology. 2001;  121 1253-1254
    PubMedSearch in Google Scholar
  • 88 Wang X W, Hussain S P, Huo T I et al.. Molecular pathogenesis of human hepatocellular carcinoma.  Toxicology. 2002;  181-182 43-47
    CrossrefPubMedSearch in Google Scholar
  • 89 Deugnier Y, Turlin B. Iron and hepatocellular carcinoma.  J Gastroenterol Hepatol. 2001;  16 491-494
    CrossrefPubMedSearch in Google Scholar
  • 90 Hatch M C, Chen C J, Levin B et al.. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan.  Int J Cancer. 1993;  54 931-934
    PubMedSearch in Google Scholar
  • 91 Van Rensburg S J, Cook-Mozaffari P, Van Schalkwyk D J, Van der Watt J J, Vincent T J, Purchase I F. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei.  Br J Cancer. 1985;  51 713-726
    PubMedSearch in Google Scholar
  • 92 Yeh F S, Yu M C, Mo C C, Luo S, Tong M J, Henderson B E. Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.  Cancer Res. 1989;  49 2506-2509
    PubMedSearch in Google Scholar
  • 93 Omer R E, Kuijsten A, Kadaru A M et al.. Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma.  Nutr Cancer. 2004;  48 15-21
    CrossrefPubMedSearch in Google Scholar
  • 94 Wang J S, Qian G S, Zarba A et al.. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.  Cancer Epidemiol Biomarkers Prev. 1996;  5 253-261
    PubMedSearch in Google Scholar
  • 95 Groopman J D. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?.  IARC Sci Publ. 1988;  (89) 55-62
    PubMedSearch in Google Scholar
  • 96 Chen C J, Wang L Y, Lu S N et al.. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma.  Hepatology. 1996;  24 38-42
    PubMedSearch in Google Scholar
  • 97 Ross R K, Yuan J M, Yu M C et al.. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.  Lancet. 1992;  339 943-946
    CrossrefPubMedSearch in Google Scholar
  • 98 Lin L, Yang F, Ye Z et al.. Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect.  Pharmacogenetics. 1991;  1 79-85
    PubMedSearch in Google Scholar
  • 99 Sun Z, Lu P, Gail M H et al.. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.  Hepatology. 1999;  30 379-383
    CrossrefPubMedSearch in Google Scholar
  • 100 Wang L Y, Hatch M, Chen C J et al.. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.  Int J Cancer. 1996;  67 620-625
    CrossrefPubMedSearch in Google Scholar
  • 101 Kew M C. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis.  Liver Int. 2003;  23 405-409
    CrossrefPubMedSearch in Google Scholar
  • 102 Wojnowski L, Turner P C, Pedersen B et al.. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa.  Pharmacogenetics. 2004;  14 691-700
    PubMedSearch in Google Scholar
  • 103 Kubicka S, Trautwein C, Niehof M, Manns M. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.  Hepatology. 1997;  25 867-873
    CrossrefPubMedSearch in Google Scholar
  • 104 Aguilar F, Hussain S P, Cerutti P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.  Proc Natl Acad Sci USA. 1993;  90 8586-8590
    PubMedSearch in Google Scholar
  • 105 Hsu I C, Metcalf R A, Sun T, Welsh J A, Wang N J, Harris C C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.  Nature. 1991;  350 427-428
    CrossrefPubMedSearch in Google Scholar
  • 106 Kirk G D, Camus-Randon A M, Mendy M et al.. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.  J Natl Cancer Inst. 2000;  92 148-153
    CrossrefPubMedSearch in Google Scholar
  • 107 Adami H O, Chow W H, Nyren O et al.. Excess risk of primary liver cancer in patients with diabetes mellitus.  J Natl Cancer Inst. 1996;  88 1472-1477
    CrossrefPubMedSearch in Google Scholar
  • 108 Lu S N, Lin T M, Chen C J et al.. A case-control study of primary hepatocellular carcinoma in Taiwan.  Cancer. 1988;  62 2051-2055
    PubMedSearch in Google Scholar
  • 109 Lawson D H, Gray J M, McKillop C, Clarke J, Lee F D, Patrick R S. Diabetes mellitus and primary hepatocellular carcinoma.  Q J Med. 1986;  61 945-955
    PubMedSearch in Google Scholar
  • 110 Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study.  Kurume Med J. 2003;  50 91-98
    PubMedSearch in Google Scholar
  • 111 Regimbeau J M, Colombat M, Mognol P et al.. Obesity and diabetes as a risk factor for hepatocellular carcinoma.  Liver Transpl. 2004;  10 S69-S73
    PubMedSearch in Google Scholar
  • 112 El-Serag H B, Tran T, Everhart J E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.  Gastroenterology. 2004;  126 460-468
    CrossrefPubMedSearch in Google Scholar
  • 113 Lagiou P, Kuper H, Stuver S O, Tzonou A, Trichopoulos D, Adami H O. Role of diabetes mellitus in the etiology of hepatocellular carcinoma.  J Natl Cancer Inst. 2000;  92 1096-1099
    CrossrefPubMedSearch in Google Scholar
  • 114 Tolman K G, Fonseca V, Tan M H, Dalpiaz A. Narrative review: hepatobiliary disease in type 2 diabetes mellitus.  Ann Intern Med. 2004;  141 946-956
    CrossrefPubMedSearch in Google Scholar
  • 115 Tazawa J, Maeda M, Nakagawa M et al.. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C.  Dig Dis Sci. 2002;  47 710-715
    CrossrefPubMedSearch in Google Scholar
  • 116 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . Tobacco smoke and involuntary smoking.  IARC Monogr Eval Carcinog Risks Hum. 2004;  83 1-1438
    PubMedSearch in Google Scholar
  • 117 Trichopoulos D, Day N E, Kaklamani E et al.. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma.  Int J Cancer. 1987;  39 45-49
    PubMedSearch in Google Scholar
  • 118 Trichopoulos D, MacMahon B, Sparros L, Merikas G. Smoking and hepatitis B-negative primary hepatocellular carcinoma.  J Natl Cancer Inst. 1980;  65 111-114
    PubMedSearch in Google Scholar
  • 119 Lam K C, Yu M C, Leung J W, Henderson B E. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong.  Cancer Res. 1982;  42 5246-5248
    PubMedSearch in Google Scholar
  • 120 Gelatti U, Covolo L, Talamini R et al.. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.  Int J Cancer. 2005;  115 301-306
    CrossrefPubMedSearch in Google Scholar
  • 121 Mori M, Hara M, Wada I et al.. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan.  Am J Epidemiol. 2000;  151 131-139
    PubMedSearch in Google Scholar
  • 122 Pyong S J, Tsukuma H, Hiyama T. Case-control study of hepatocellular carcinoma among Koreans living in Osaka, Japan.  Jpn J Cancer Res. 1994;  85 674-679
    PubMedSearch in Google Scholar
  • 123 Shin H R, Lee C U, Park H J et al.. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea.  Int J Epidemiol. 1996;  25 933-940
    PubMedSearch in Google Scholar
  • 124 Tsukuma H, Hiyama T, Tanaka S et al.. Risk factors for hepatocellular carcinoma among patients with chronic liver disease.  N Engl J Med. 1993;  328 1797-1801
    CrossrefPubMedSearch in Google Scholar
  • 125 Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer.  Int J Cancer. 1984;  34 775-779
    PubMedSearch in Google Scholar
  • 126 Chiba T, Matsuzaki Y, Abei M et al.. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.  Am J Gastroenterol. 1996;  91 1195-1203
    PubMedSearch in Google Scholar
  • 127 Chen S Y, Wang L Y, Lunn R M et al.. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.  Int J Cancer. 2002;  99 14-21
    CrossrefPubMedSearch in Google Scholar
  • 128 Yu M W, Pai C I, Yang S Y et al.. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.  Gut. 2000;  47 703-709
    CrossrefPubMedSearch in Google Scholar
  • 129 Younossi Z M, McCullough A J, Ong J P et al.. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.  J Clin Gastroenterol. 2004;  38 705-709
    PubMedSearch in Google Scholar
  • 130 Anagnostopoulos G K, Arvanitidis D, Tsiakos S, Margantinis G, Grigoriadis K, Kostopoulos P. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?.  J Clin Gastroenterol. 2003;  37 88-89
    CrossrefPubMedSearch in Google Scholar
  • 131 Bencheqroun R, Duvoux C, Luciani A, Zafrani E S, Dhumeaux D. [Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis].  Gastroenterol Clin Biol. 2004;  28 497-499
    PubMedSearch in Google Scholar
  • 132 Bullock R E, Zaitoun A M, Aithal G P, Ryder S D, Beckingham I J, Lobo D N. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.  J Hepatol. 2004;  41 685-686
    CrossrefPubMedSearch in Google Scholar
  • 133 Cuadrado A, Orive A, Garcia-Suarez C et al.. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.  Obes Surg. 2005;  15 442-446
    PubMedSearch in Google Scholar
  • 134 Marrero J A, Fontana R J, Su G L, Conjeevaram H S, Emick D M, Lok A S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.  Hepatology. 2002;  36 1349-1354
    CrossrefPubMedSearch in Google Scholar
  • 135 Mori S, Yamasaki T, Sakaida I et al.. Hepatocellular carcinoma with nonalcoholic steatohepatitis.  J Gastroenterol. 2004;  39 391-396
    CrossrefPubMedSearch in Google Scholar
  • 136 Orikasa H, Ohyama R, Tsuka N, Eyden B P, Yamazaki K. Lipid-rich clear-cell hepatocellular carcinoma arising in non-alcoholic steatohepatitis in a patient with diabetes mellitus.  J Submicrosc Cytol Pathol. 2001;  33 195-200
    PubMedSearch in Google Scholar
  • 137 Shimada M, Hashimoto E, Taniai M et al.. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis.  J Hepatol. 2002;  37 154-160
    CrossrefPubMedSearch in Google Scholar
  • 138 Yoshioka Y, Hashimoto E, Yatsuji S et al.. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.  J Gastroenterol. 2004;  39 1215-1218
    CrossrefPubMedSearch in Google Scholar
  • 139 Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis.  Pathol Int. 2001;  51 127-131
    PubMedSearch in Google Scholar
  • 140 Hashimoto E, Taniai M, Kaneda H et al.. Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.  Alcohol Clin Exp Res. 2004;  28 164S-168S
    PubMedSearch in Google Scholar
  • 141 Yang S, Lin H Z, Hwang J, Chacko V P, Diehl A M. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?.  Cancer Res. 2001;  61 5016-5023
    PubMedSearch in Google Scholar
  • 142 Lonardo A, Bagni A, Tarugi P, Loria P. The wide spectrum of steatohepatitis: a report of four cases and a review of the literature.  Eur J Gastroenterol Hepatol. 2004;  16 1043-1050
    PubMedSearch in Google Scholar
  • 143 Nair S, Mason A, Eason J, Loss G, Perrillo R P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?.  Hepatology. 2002;  36 150-155
    CrossrefPubMedSearch in Google Scholar
  • 144 Ratziu V, Bonyhay L, Di Martino V et al.. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis.  Hepatology. 2002;  35 1485-1493
    CrossrefPubMedSearch in Google Scholar
  • 145 Caldwell S H, Crespo D M, Kang H S, Al-Osaimi A M. Obesity and hepatocellular carcinoma.  Gastroenterology. 2004;  127 S97-103
    CrossrefPubMedSearch in Google Scholar
  • 146 Huo T I, Wu J C, Lee S D. Are alcohol, tobacco and obesity genuine risk factors for hepatocellular carcinoma?.  J Hepatol. 2005;  42 941
    PubMedSearch in Google Scholar
  • 147 Suriawinata A, Fiel M I. Liver pathology in obesity.  Semin Liver Dis. 2004;  24 363-370
    Thieme ConnectPubMedSearch in Google Scholar
  • 148 Donato F, Gelatti U, Tagger A et al.. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy.  Cancer Causes Control. 2001;  12 959-964
    CrossrefPubMedSearch in Google Scholar
  • 149 Parkin D M, Ohshima H, Srivatanakul P, Vatanasapt V. Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.  Cancer Epidemiol Biomarkers Prev. 1993;  2 537-544
    PubMedSearch in Google Scholar
  • 150 Shaib Y H, El-Serag H B, Davila J A, Morgan R, McGlynn K A. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.  Gastroenterology. 2005;  128 620-626
    CrossrefPubMedSearch in Google Scholar
  • 151 Kuper H, Lagiou P, Mucci L A, Tamimi R, Benetou V, Trichopoulos D. Risk factors for cholangiocarcinoma in a low risk Caucasian population.  Soz Praventivmed. 2001;  46 182-185
    PubMedSearch in Google Scholar
  • 152 Parkin D M, Srivatanakul P, Khlat M et al.. Liver cancer in Thailand. I: a case-control study of cholangiocarcinoma.  Int J Cancer. 1991;  48 323-328
    CrossrefPubMedSearch in Google Scholar
  • 153 Sorensen H T, Friis S, Olsen J H et al.. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark.  Hepatology. 1998;  28 921-925
    CrossrefPubMedSearch in Google Scholar
  • 154 Altaee M Y, Johnson P J, Farrant J M, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.  Cancer. 1991;  68 2051-2055
    PubMedSearch in Google Scholar
  • 155 Su W C, Chan K K, Lin X Z et al.. A clinical study of 130 patients with biliary tract cancers and periampullary tumors.  Oncology. 1996;  53 488-493
    PubMedSearch in Google Scholar
  • 156 Pinyosophon A, Wiwanitkit V. The prevalence of hepatitis B seropositivity among patients with cholangiocarcinoma.  Viral Immunol. 2002;  15 655-657
    CrossrefPubMedSearch in Google Scholar
  • 157 Songsivilai S, Dharakul T, Kanistanon D. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand.  Trans R Soc Trop Med Hyg. 1996;  90 505-507
    CrossrefPubMedSearch in Google Scholar
  • 158 Yamamoto S, Kubo S, Hai S et al.. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma.  Cancer Sci. 2004;  95 592-595
    CrossrefPubMedSearch in Google Scholar
  • 159 Kobayashi M, Ikeda K, Saitoh S et al.. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis.  Cancer. 2000;  88 2471-2477
    CrossrefPubMedSearch in Google Scholar
  • 160 Lu H, Ye M Q, Thung S N, Dash S, Gerber M A. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients.  Chin Med J (Engl). 2000;  113 1138-1141
    PubMedSearch in Google Scholar
  • 161 Polizos A, Kelekis N, Sinani C, Patsiaoura K, Papadamou G, Dalekos G N. Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: case report and review of the literature.  Eur J Gastroenterol Hepatol. 2003;  15 331-334
    PubMedSearch in Google Scholar
  • 162 Bergquist A, Ekbom A, Olsson R et al.. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.  J Hepatol. 2002;  36 321-327
    CrossrefPubMedSearch in Google Scholar
  • 163 Boberg K M, Bergquist A, Mitchell S et al.. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.  Scand J Gastroenterol. 2002;  37 1205-1211
    CrossrefPubMedSearch in Google Scholar
  • 164 Broome U, Olsson R, Loof L et al.. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.  Gut. 1996;  38 610-615
    PubMedSearch in Google Scholar
  • 165 Burak K, Angulo P, Pasha T M, Egan K, Petz J, Lindor K D. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.  Am J Gastroenterol. 2004;  99 523-526
    CrossrefPubMedSearch in Google Scholar
  • 166 Ponsioen C Y, Vrouenraets S M, Prawirodirdjo W et al.. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.  Gut. 2002;  51 562-566
    CrossrefPubMedSearch in Google Scholar
  • 167 Bjornsson E, Boberg K M, Cullen S et al.. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.  Gut. 2002;  51 731-735
    CrossrefPubMedSearch in Google Scholar
  • 168 Boberg K M, Schrumpf E, Bergquist A et al.. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.  J Hepatol. 2000;  32 374-380
    CrossrefPubMedSearch in Google Scholar
  • 169 Boberg K M, Spurkland A, Rocca G et al.. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.  Scand J Gastroenterol. 2001;  36 886-890
    PubMedSearch in Google Scholar
  • 170 Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.  Hepatology. 1998;  27 311-316
    CrossrefPubMedSearch in Google Scholar
  • 171 Chalasani N, Baluyut A, Ismail A et al.. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.  Hepatology. 2000;  31 7-11
    CrossrefPubMedSearch in Google Scholar
  • 172 Kornfeld D, Ekbom A, Ihre T. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: a population-based study.  Scand J Gastroenterol. 1997;  32 1042-1045
    PubMedSearch in Google Scholar
  • 173 International Agency for Research on Cancer Working Group . Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis).  IARC Monogr Eval Carcinog Risks Hum. 1994;  61 121-175
    PubMedSearch in Google Scholar
  • 174 Schwartz D A. Cholangiocarcinoma associated with liver fluke infection: a preventable source of morbidity in Asian immigrants.  Am J Gastroenterol. 1986;  81 76-79
    PubMedSearch in Google Scholar
  • 175 Stauffer W M, Sellman J S, Walker P F. Biliary liver flukes (Opisthorchiasis and Clonorchiasis) in immigrants in the United States: often subtle and diagnosed years after arrival.  J Travel Med. 2004;  11 157-159
    PubMedSearch in Google Scholar
  • 176 Chapman R W. Risk factors for biliary tract carcinogenesis.  Ann Oncol. 1999;  10(suppl 4) 308-311
    CrossrefPubMedSearch in Google Scholar
  • 177 Choi B I, Han J K, Hong S T, Lee K H. Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.  Clin Microbiol Rev. 2004;  17 540-552
    CrossrefPubMedSearch in Google Scholar
  • 178 Hong S T, Kho W G, Kim W H, Chai J Y, Lee S H. Turnover of biliary epithelial cells in Clonorchis sinensis infected rats.  Korean J Parasitol. 1993;  31 83-89
    PubMedSearch in Google Scholar
  • 179 Hou P C. The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis .  J Pathol Bacteriol. 1956;  72 239-246
    CrossrefPubMedSearch in Google Scholar
  • 180 Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin D M. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand.  Trop Med Int Health. 2004;  9 588-594
    PubMedSearch in Google Scholar
  • 181 Pairojkul C, Shirai T, Hirohashi S et al.. Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand.  Princess Takamatsu Symp. 1991;  22 77-86
    PubMedSearch in Google Scholar
  • 182 Haswell-Elkins M R, Mairiang E, Mairiang P et al.. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand.  Int J Cancer. 1994;  59 505-509
    PubMedSearch in Google Scholar
  • 183 Itoh M, Pairojkul C, Thamawit W et al.. Association of antibodies to Opisthorchis viverrini with hepatobiliary disease in northeastern Thailand.  Am J Trop Med Hyg. 1994;  51 424-429
    PubMedSearch in Google Scholar
  • 184 Pinlaor S, Hiraku Y, Ma N et al.. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis.  Nitric Oxide. 2004;  11 175-183
    CrossrefPubMedSearch in Google Scholar
  • 185 Pinlaor S, Tada-Oikawa S, Hiraku Y et al.. Opisthorchis viverrini antigen induces the expression of Toll-like receptor 2 in macrophage RAW cell line.  Int J Parasitol. 2005;  35 591-596
    PubMedSearch in Google Scholar
  • 186 Lee C C, Wu C Y, Chen G H. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?.  J Gastroenterol Hepatol. 2002;  17 1015-1020
    CrossrefPubMedSearch in Google Scholar
  • 187 Chen D W, Tung-Ping Poon R, Liu C L, Fan S T, Wong J. Immediate and long-term outcomes of hepatectomy for hepatolithiasis.  Surgery. 2004;  135 386-393
    CrossrefPubMedSearch in Google Scholar
  • 188 Chen M F, Jan Y Y, Wang C S et al.. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis.  Cancer. 1993;  71 2461-2465
    CrossrefPubMedSearch in Google Scholar
  • 189 Chijiiwa K, Ohtani K, Noshiro H et al.. Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis.  Hepatogastroenterology. 2002;  49 96-99
    PubMedSearch in Google Scholar
  • 190 Wang Y J, Lee S D, Shyu J K, Lo K J. Clinical experience in 126 patients with tissue-proved proximal cholangiocarcinoma.  J Gastroenterol Hepatol. 1994;  9 134-137
    PubMedSearch in Google Scholar
  • 191 Lesurtel M, Regimbeau J M, Farges O, Colombat M, Sauvanet A, Belghiti J. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.  Eur J Gastroenterol Hepatol. 2002;  14 1025-1027
    CrossrefPubMedSearch in Google Scholar
  • 192 Lee K T, Liu T S. Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma.  World J Surg. 2003;  27 1143-1148
    CrossrefPubMedSearch in Google Scholar
  • 193 Terada T, Ashida K, Endo K et al.. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.  Histopathology. 1998;  33 325-331
    CrossrefPubMedSearch in Google Scholar
  • 194 Liu D, Momoi H, Li L, Ishikawa Y, Fukumoto M. Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma.  Int J Cancer. 2002;  102 366-371
    CrossrefPubMedSearch in Google Scholar
  • 195 Sharp G B. The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data.  J Radiat Res (Tokyo). 2002;  43 371-380
    PubMedSearch in Google Scholar
  • 196 Yamada S, Hosoda S, Tateno H, Kido C, Takahashi S. Survey of thorotrast-associated liver cancers in Japan.  J Natl Cancer Inst. 1983;  70 31-35
    PubMedSearch in Google Scholar
  • 197 Lipsett P A, Pitt H A, Colombani P M, Boitnott J K, Cameron J L. Choledochal cyst disease: a changing pattern of presentation.  Ann Surg. 1994;  220 644-652
    PubMedSearch in Google Scholar
  • 198 Nakeeb A, Pitt H A, Sohn T A et al.. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors.  Ann Surg. 1996;  224 463-473 , discussion 473-5
    CrossrefPubMedSearch in Google Scholar
  • 199 de Vries J S, de Vries S, Aronson D C et al.. Choledochal cysts: age of presentation, symptoms, and late complications related to Todani's classification.  J Pediatr Surg. 2002;  37 1568-1573
    CrossrefPubMedSearch in Google Scholar
  • 200 Goto N, Yasuda I, Uematsu T et al.. Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation.  J Gastroenterol. 2001;  36 856-862
    CrossrefPubMedSearch in Google Scholar
  • 201 DiBisceglie A M. Malignant neoplasms of the liver. In: Schiff ER, Sorrell MF, Maddrey WC Schiff's Diseases of the Liver. 8th ed. Philadelphia; Lippincott Raven 1999: 1294
    Search in Google Scholar
  • 202 Saab S, Yao F. Fibrolamellar hepatocellular carcinoma: case reports and a review of the literature.  Dig Dis Sci. 1996;  41 1981-1985
    CrossrefPubMedSearch in Google Scholar
  • 203 El-Serag H B, Davila J A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.  Hepatology. 2004;  39 798-803
    CrossrefPubMedSearch in Google Scholar
  • 204 Sooklim K, Sriplung H, Piratvisuth T. Histologic subtypes of hepatocellular carcinoma in the southern Thai population.  Asian Pac J Cancer Prev. 2003;  4 302-306
    PubMedSearch in Google Scholar
  • 205 Dadke D, Jaganath P, Krishnamurthy S, Chiplunkar S. The detection of HBV antigens and HBx-transcripts in an Indian fibrolamellar carcinoma patient: a case study.  Liver. 2002;  22 87-91
    PubMedSearch in Google Scholar
  • 206 Fong Y, Kemeny N, Lawrence T S. Cancer of the liver and biliary tree. In: Devita VT, Hellman S, Rosenberg SA Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia; Lippincott Williams and Wilkins 2001: 1177-1178
    Search in Google Scholar
  • 207 Lee C L, Ko Y C. Survival and distribution pattern of childhood liver cancer in Taiwan.  Eur J Cancer. 1998;  34 2064-2067
    CrossrefPubMedSearch in Google Scholar
  • 208 Bortolasi L, Marchiori L, Dal Dosso I, Colombari R, Nicoli N. Hepatoblastoma in adult age: a report of two cases.  Hepatogastroenterology. 1996;  43 1073-1078
    PubMedSearch in Google Scholar
  • 209 Bunin G R. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies.  Toxicol Appl Pharmacol. 2004;  199 91-103
    CrossrefPubMedSearch in Google Scholar
  • 210 Feusner J, Plaschkes J. Hepatoblastoma and low birth weight: a trend or chance observation?.  Med Pediatr Oncol. 2002;  39 508-509
    CrossrefPubMedSearch in Google Scholar
  • 211 Ikeda H, Matsuyama S, Tanimura M. Association between hepatoblastoma and very low birth weight: a trend or a chance?.  J Pediatr. 1997;  130 557-560
    PubMedSearch in Google Scholar
  • 212 DiBisceglie A M. Malignant neoplasms of the liver. In: Schiff ER, Sorrell MF, Maddrey WC Schiff's Diseases of the Liver. 8th ed. Philadelphia; Lippincott Raven 1999: 1281-1304
    Search in Google Scholar
  • 213 Mani H, Van Thiel D H. Mesenchymal tumors of the liver.  Clin Liver Dis. 2001;  5 219-257 , viii
    CrossrefPubMedSearch in Google Scholar
  • 214 Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma.  Dig Dis Sci. 2003;  48 677-682
    CrossrefPubMedSearch in Google Scholar
  • 215 Falk H, Herbert J, Crowley S et al.. Epidemiology of hepatic angiosarcoma in the United States: 1964-1974.  Environ Health Perspect. 1981;  41 107-113
    PubMedSearch in Google Scholar
  • 216 Hozo I, Miric D, Bojic L et al.. Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer.  Environ Health Perspect. 2000;  108 793-795
    PubMedSearch in Google Scholar
  • 217 Kielhorn J, Melber C, Wahnschaffe U, Aitio A, Mangelsdorf I. Vinyl chloride: still a cause for concern.  Environ Health Perspect. 2000;  108 579-588
    PubMedSearch in Google Scholar
  • 218 Lee F I, Smith P M, Bennett B, Williams D M. Occupationally related angiosarcoma of the liver in the United Kingdom 1972-1994.  Gut. 1996;  39 312-318
    PubMedSearch in Google Scholar
  • 219 Falk H, Caldwell G G, Ishak K G, Thomas L B, Popper H. Arsenic-related hepatic angiosarcoma.  Am J Ind Med. 1981;  2 43-50
    PubMedSearch in Google Scholar
  • 220 Roat J W, Wald A, Mendelow H, Pataki K I. Hepatic angiosarcoma associated with short-term arsenic ingestion.  Am J Med. 1982;  73 933-936
    CrossrefPubMedSearch in Google Scholar
  • 221 Ito Y, Kojiro M, Nakashima T, Mori T. Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma.  Cancer. 1988;  62 1153-1162
    PubMedSearch in Google Scholar
  • 222 Przygodzki R M, Finkelstein S D, Keohavong P et al.. Sporadic and thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.  Lab Invest. 1997;  76 153-159
    PubMedSearch in Google Scholar
  • 223 Falk H, Thomas L B, Popper H, Ishak K G. Hepatic angiosarcoma associated with androgenic-anabolic steroids.  Lancet. 1979;  2 1120-1123
    PubMedSearch in Google Scholar
  • 224 Rosenthal A K, Klausmeier M, Cronin M E, McLaughlin J K. Hepatic angiosarcoma occurring after cyclophosphamide therapy: case report and review of the literature.  Am J Clin Oncol. 2000;  23 581-583
    CrossrefPubMedSearch in Google Scholar
  • 225 DiBisceglie A M. Malignant neoplasms of the liver. In: Schiff ER, Sorrell MF, Maddrey WC Schiff's Diseases of the Liver. 8th ed. Philadelphia; Lippincott Raven 1999: 1300
    Search in Google Scholar
  • 226 Ayoub J P, Hess K R, Abbruzzese M C, Lenzi R, Raber M N, Abbruzzese J L. Unknown primary tumors metastatic to liver.  J Clin Oncol. 1998;  16 2105-2112
    CrossrefPubMedSearch in Google Scholar
  • 227 Kew M C. Hepatic tumors and cysts. In: Feldman M, Friedman LS, Sleisenger MH, Scharschmidt BF Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/ Management. 7th ed. Philadelphia; Saunders 2002: 1589-1590
    Search in Google Scholar
  • 228 Hoe A L, Royle G T, Taylor I. Breast liver metastases: incidence, diagnosis and outcome.  J R Soc Med. 1991;  84 714-716
    PubMedSearch in Google Scholar
  • 229 Gorog D, Toth A, Weltner J. Prognosis of untreated liver metastasis from rectal cancer.  Acta Chir Hung. 1997;  36 106-107
    PubMedSearch in Google Scholar
  • 230 Alexander H R, Allegra C J, Lawrence T S. Metastatic cancer to the liver. In: Devita VT, Hellman S, Rosenberg SA Cancer: Principles and Practice of Oncology. 6th ed. Philadelphia; Lippincott Williams and Wilkins 2001: 2690
    Search in Google Scholar
  • 231 Ferlito A, Shaha A R, Silver C E, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer.  ORL J Otorhinolaryngol Relat Spec. 2001;  63 202-207
    CrossrefPubMedSearch in Google Scholar
  • 232 Bralet M, Regimbeau J, Pineau P et al.. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases.  Hepatology. 2000;  32 200-204
    CrossrefPubMedSearch in Google Scholar

Kia SaeianM.D. M.Sc. 

Division of Gastroenterology and Hepatology, Medical College of Wisconsin

9200 W. Wisconsin Avenue, Milwaukee, WI 53226